SG11202012715UA - Recombinant adeno-associated virus products and methods for treating limb girdle muscular dystrophy 2a - Google Patents
Recombinant adeno-associated virus products and methods for treating limb girdle muscular dystrophy 2aInfo
- Publication number
- SG11202012715UA SG11202012715UA SG11202012715UA SG11202012715UA SG11202012715UA SG 11202012715U A SG11202012715U A SG 11202012715UA SG 11202012715U A SG11202012715U A SG 11202012715UA SG 11202012715U A SG11202012715U A SG 11202012715UA SG 11202012715U A SG11202012715U A SG 11202012715UA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- associated virus
- muscular dystrophy
- recombinant adeno
- girdle muscular
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14131—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862691934P | 2018-06-29 | 2018-06-29 | |
| US201962865081P | 2019-06-21 | 2019-06-21 | |
| PCT/US2019/039893 WO2020006458A1 (en) | 2018-06-29 | 2019-06-28 | Recombinant adeno-associated virus products and methods for treating limb girdle muscular dystrophy 2a |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202012715UA true SG11202012715UA (en) | 2021-01-28 |
Family
ID=67544319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202012715UA SG11202012715UA (en) | 2018-06-29 | 2019-06-28 | Recombinant adeno-associated virus products and methods for treating limb girdle muscular dystrophy 2a |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210277362A1 (ja) |
| EP (1) | EP3814514A1 (ja) |
| JP (1) | JP2021528983A (ja) |
| KR (1) | KR20210028162A (ja) |
| CN (1) | CN112543810A (ja) |
| AU (1) | AU2019295779A1 (ja) |
| BR (1) | BR112020026853A2 (ja) |
| CA (1) | CA3105216A1 (ja) |
| CL (1) | CL2020003384A1 (ja) |
| CO (1) | CO2021000914A2 (ja) |
| IL (1) | IL279789A (ja) |
| MX (1) | MX2020014119A (ja) |
| SG (1) | SG11202012715UA (ja) |
| TW (1) | TW202020161A (ja) |
| WO (1) | WO2020006458A1 (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202208630A (zh) | 2020-06-15 | 2022-03-01 | 美國全美兒童醫院之研究學會 | 針對肌肉營養不良症的腺相關病毒載體遞送 |
| EP4108263A3 (en) | 2021-06-02 | 2023-03-22 | Research Institute at Nationwide Children's Hospital | Recombinant adeno-associated virus products and methods for treating limb girdle muscular dystrophy 2a |
| USD1008419S1 (en) * | 2021-06-14 | 2023-12-19 | Jong Won Kim | Vent valve of a wastewater drainage pipe |
| EP4198048A1 (en) | 2021-12-16 | 2023-06-21 | Genethon | Calpain-3 gene transfer increase using modified itr sequences |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| ATE272123T1 (de) | 1993-11-09 | 2004-08-15 | Ohio Med College | Stabile zellinie, die in der lage ist, das replikationsgen des adenoassoziertenvirus zu exprimieren |
| DE69433592T2 (de) | 1993-11-09 | 2005-02-10 | Targeted Genetics Corp., Seattle | Die erzielung hoher titer des rekombinanten aav-vektors |
| US5658785A (en) | 1994-06-06 | 1997-08-19 | Children's Hospital, Inc. | Adeno-associated virus materials and methods |
| US5856152A (en) | 1994-10-28 | 1999-01-05 | The Trustees Of The University Of Pennsylvania | Hybrid adenovirus-AAV vector and methods of use therefor |
| JPH10511264A (ja) | 1994-12-06 | 1998-11-04 | ターゲティッド ジェネティックス コーポレイション | 高力価組換えａａｖベクターの生成のためのパッケージング細胞株 |
| FR2737730B1 (fr) | 1995-08-10 | 1997-09-05 | Pasteur Merieux Serums Vacc | Procede de purification de virus par chromatographie |
| CA2230655C (en) | 1995-08-30 | 2008-06-17 | Genzyme Corporation | Chromatographic purification of adenovirus and aav |
| EP0850313B8 (en) | 1995-09-08 | 2009-07-29 | Genzyme Corporation | Improved aav vectors for gene therapy |
| US5910434A (en) | 1995-12-15 | 1999-06-08 | Systemix, Inc. | Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant |
| IL128779A0 (en) | 1996-09-06 | 2000-01-31 | Univ Pennsylvania | Method for recombinant adeno-associated virus-directed gene therapy |
| CA2995542A1 (en) | 1997-09-05 | 1999-03-11 | Genzyme Corporation | Methods for generating high titer helper-free preparations of recombinant aav vectors |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| US6258595B1 (en) | 1999-03-18 | 2001-07-10 | The Trustees Of The University Of Pennsylvania | Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| CA2406743A1 (en) | 2000-04-28 | 2001-11-08 | The Trustees Of The University Of Pennsylvania | Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids |
| AU2002248297A1 (en) | 2001-01-05 | 2002-07-16 | Children's Hospital, Inc. | Aav2 vectors and methods |
| WO2013078316A1 (en) | 2011-11-23 | 2013-05-30 | Nationwide Children's Hospital, Inc. | Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides |
| DE102012007232B4 (de) | 2012-04-07 | 2014-03-13 | Susanne Weller | Verfahren zur Herstellung von rotierenden elektrischen Maschinen |
| FR3004463A1 (fr) * | 2013-04-11 | 2014-10-17 | Genethon | Systeme d'expression pour une therapie genique selective |
| JP2015092462A (ja) | 2013-09-30 | 2015-05-14 | Tdk株式会社 | 正極及びそれを用いたリチウムイオン二次電池 |
| JP6202701B2 (ja) | 2014-03-21 | 2017-09-27 | 株式会社日立国際電気 | 基板処理装置、半導体装置の製造方法及びプログラム |
| JP6197169B2 (ja) | 2014-09-29 | 2017-09-20 | 東芝メモリ株式会社 | 半導体装置の製造方法 |
| KR20180081600A (ko) * | 2015-11-16 | 2018-07-16 | 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 | 티틴-기반 근증 및 다른 티틴성병증의 치료를 위한 물질 및 방법 |
| CN117384964A (zh) * | 2016-04-15 | 2024-01-12 | 全国儿童医院研究所 | 腺相关病毒载体递送β-肌聚糖和微RNA-29以及肌营养不良症的治疗 |
-
2019
- 2019-06-28 MX MX2020014119A patent/MX2020014119A/es unknown
- 2019-06-28 TW TW108123006A patent/TW202020161A/zh unknown
- 2019-06-28 CN CN201980044250.6A patent/CN112543810A/zh active Pending
- 2019-06-28 KR KR1020207037223A patent/KR20210028162A/ko unknown
- 2019-06-28 EP EP19749867.8A patent/EP3814514A1/en active Pending
- 2019-06-28 JP JP2020572953A patent/JP2021528983A/ja active Pending
- 2019-06-28 AU AU2019295779A patent/AU2019295779A1/en active Pending
- 2019-06-28 BR BR112020026853-4A patent/BR112020026853A2/pt unknown
- 2019-06-28 CA CA3105216A patent/CA3105216A1/en active Pending
- 2019-06-28 WO PCT/US2019/039893 patent/WO2020006458A1/en active Application Filing
- 2019-06-28 SG SG11202012715UA patent/SG11202012715UA/en unknown
- 2019-06-28 US US17/255,488 patent/US20210277362A1/en active Pending
-
2020
- 2020-12-24 CL CL2020003384A patent/CL2020003384A1/es unknown
- 2020-12-27 IL IL279789A patent/IL279789A/en unknown
-
2021
- 2021-01-28 CO CONC2021/0000914A patent/CO2021000914A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3814514A1 (en) | 2021-05-05 |
| US20210277362A1 (en) | 2021-09-09 |
| JP2021528983A (ja) | 2021-10-28 |
| BR112020026853A2 (pt) | 2021-04-20 |
| CO2021000914A2 (es) | 2021-02-08 |
| CA3105216A1 (en) | 2020-01-02 |
| KR20210028162A (ko) | 2021-03-11 |
| AU2019295779A1 (en) | 2021-01-28 |
| TW202020161A (zh) | 2020-06-01 |
| WO2020006458A1 (en) | 2020-01-02 |
| CN112543810A (zh) | 2021-03-23 |
| MX2020014119A (es) | 2021-06-18 |
| IL279789A (en) | 2021-03-01 |
| CL2020003384A1 (es) | 2021-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279789A (en) | Recombinant Adeno-Associated Virus Products and Methods for the Treatment of Limb-Girdle Muscular Dystrophy 2A | |
| IL272412A (en) | Cytokine conjugates for the treatment of infectious diseases and cell culture | |
| HK1251219A1 (zh) | 用於治療和預防乙型肝炎病毒感染的新的6，7-二氫吡啶並[2，1-a]酞嗪-2-酮類化合物 | |
| ZA201806863B (en) | Adeno-associated virus vector delivery of b-sarcoglycan and microrna-29 and the treatment of muscular dystrophy | |
| SG11202005772YA (en) | Mhc class i associated peptides for prevention and treatment of multiple flavi virus | |
| ZA201905851B (en) | Peptides and methods for the treatment of diabetes | |
| FI3773689T3 (fi) | Antigeenisiä peptidejä syövän ehkäisyyn ja hoitoon | |
| IL288533A (en) | Recombinant oncolytic virus, method for its preparation, use thereof and drug. | |
| PT3612475T (pt) | Instalação de tratamento | |
| IL285849A (en) | Delivery of b-sarcoglycan using an adeno-associated virus vector and treatment of muscular dystrophy | |
| IL272121A (en) | Preparation and methods for the treatment of myopia | |
| IL284029B1 (en) | Peptides for the treatment and prevention of diabetes and related disorders | |
| PL3641795T3 (pl) | Sposoby i materiały do leczenia naczyń krwionośnych | |
| IL272094A (en) | Antibodies and methods for the diagnosis and treatment of hepatitis B virus infection | |
| IL290734A (en) | Administration of alpha-sarcoglycan adeno-associated virus vector and treatment of muscular dystrophy | |
| GB201801553D0 (en) | Splinting apparatus and method | |
| ZA202105143B (en) | Pharmaceutical preparation for treating hepatitis b, preparation method therefor and use thereof | |
| PT4021505T (pt) | Medicamento para o tratamento de doenças infecciosas | |
| EP3261439A4 (en) | METHOD AND MATERIALS FOR TREATING HUMAN IMMUNE WEAKAGE VIRUS INFECTIONS | |
| GB201913592D0 (en) | Product for therapy and methods | |
| GB201810635D0 (en) | Peptides and cancer treatment | |
| HUE055697T2 (hu) | Eljárás és berendezés részecske alakú termékek folyamatos ózon alapú kezelésére, ahol a berendezés eszközöket tartalmaz ezen termékek továbbítására és vibráltatására | |
| IL268844A (en) | Peptides and methods of treating dystrophy-related diseases by them | |
| EP3773328C0 (en) | POLAND SYNDROME AND TREATMENT METHODS | |
| IL292599A (en) | tmem219 antibodies and medical uses thereof |